Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Eisuke Katsuda is active.

Publication


Featured researches published by Eisuke Katsuda.


Tumori | 2017

The ATS/ERS/JRS/ALAT statement “IPF by HRCT” could predict acute exacerbation of interstitial lung disease in non-small cell lung cancer

Nobuhiro Asai; Eisuke Katsuda; Rie Hamanaka; Kenshi Kosaka; Ayako Matsubara; Masaki Nishimura; Hiroyuki Tanaka; Norihito Yokoe; Ayumu Takahashi; Etsuro Yamaguchi; Akihito Kubo

Introduction Patients with non-small cell lung cancer (NSCLC) and interstitial lung disease (ILD) are at high risk of acute exacerbation of ILD (AE-ILD) when treated with systemic chemotherapy. Standard treatment for NSCLC complicated by ILD has not been established. Purpose and methods To examine whether the type of ILD categorized by the official ATS/ERS/JRS/ALAT statement as “idiopathic pulmonary fibrosis (IPF) by high-resolution computed tomography (HRCT)” could predict chemotherapy-induced AE-ILD in NSCLC patients with ILD, we retrospectively reviewed all patients with NSCLC complicated by ILD who had received chemotherapy at our institute from January 2007 until December 2013. Patients’ characteristics, pathology and clinical staging of lung cancer, chemotherapy, type of ILD and AE-ILD during chemotherapy were evaluated. ILD was classified according to the statement as follows: usual interstitial pneumonia (UIP), possible UIP, and inconsistent with a UIP pattern. Results A total of 46 patients had pre-existing ILD and received chemotherapy. The mean age was 73 years (range 46-83 years). Fifteen (32.6%) of 46 patients with ILD developed chemotherapy-induced AE-ILD, which was seen more frequently in patients with ILD with a UIP pattern or possible UIP pattern than in patients with a pattern inconsistent with UIP (80% versus 9.7%, p<0.001). Multivariate analyses including age, sex, performance status and radiographic patterns of ILD showed that the presence of a UIP or possible UIP pattern was an independent risk factor for chemotherapy-induced AE-ILD. Conclusions ILD with a UIP pattern or possible UIP pattern by the classification could be a risk factor for AE-ILD in NSCLC patients with ILD.


Japanese Journal of Radiology | 2009

Emergent coil embolization for ruptured renal artery aneurysm

Makiyo Hagihara; Akira Kitagawa; Yuichiro Izumi; Yukihiko Ohshima; Eisuke Katsuda; Joe Matsuda; Seiji Kamei; Junko Kimura; Toshiki Kawamura; Tsuneo Ishiguchi

We report a case of ruptured renal artery aneurysm successfully treated by emergent transcatheter embolization with microcoils. A 66-year-old woman was referred for emergency treatment after presenting with sudden-onset left flank pain and vomiting. Blood examination showed anemia. Computed tomography demonstrated a partly calcified mass with massive retroperitoneal hematoma. With the diagnosis of a ruptured left renal artery aneurysm, emergency angiography was performed. Left renal arteriography demonstrated a saccular aneurysm at the lower aspect of the renal hilum. A total of five microcoils were placed at the arterial branch, including the orifice of the aneurysm. The first coil was partly lodged in a branch near the orifice of the aneurysm that was used as an “anchor” to prevent subsequent coils from migrating and effectively occluding the parent artery with a short segment. Two branches originating from the renal hilum were preserved. The postoperative course was favorable. Endovascular treatments, including coil embolization, appear to be effective, safe, and less invasive than surgery. This method should be considered as a treatment of choice for ruptured renal artery aneurysm.


Clinical Imaging | 2012

18F-Fluorodeoxyglucose uptake and apparent diffusion coefficient in lung schwannoma

Toshiki Ushiyama; Eisuke Katsuda; Motoya Tanaka; Hiroki Numanami; Emiko Takahashi; Kenji Baba; Etsuro Yamaguchi; Toyoharu Yokoi; Masayuki Haniuda; Akihito Kubo

Intrapulmonary schwannoma is uncommon and preoperative radiological diagnosis is rare. Described is a schwannoma that developed as a pulmonary hilar nodule in a 38-year-old woman. The nodule showed strong (18)F-fluorodeoxyglucose uptake with a maximum standard uptake value of 5.98 on positron emission tomography and had a high apparent diffusion coefficient (2.5 × 10(3) mm(2)/s) on diffusion-weighted magnetic resonance imaging. Combination of these functional imaging techniques warrants further evaluation in radiological diagnosis of intrapulmonary schwannoma.


Internal Medicine | 2017

Interstitial Lung Disease after Pleurodesis for Malignant Pleural Effusion

Norihito Yokoe; Eisuke Katsuda; Kenshi Kosaka; Rie Hamanaka; Ayako Matsubara; Masaki Nishimura; Hiroyuki Tanaka; Nobuhiro Asai; Ayumu Takahashi; Toshiki Kawamura; Tsuneo Ishiguchi; Etsuro Yamaguchi; Akihito Kubo

Objective Pleurodesis is an effective therapy for malignant pleural effusion (MPE). While interstitial lung disease (ILD) has been regarded as a serious complication of pleurodesis, its clinicopathological characteristics have not been fully understood. This study was conducted to elucidate the incidence of ILD and the risk factors for ILD in patients who underwent pleurodesis to control MPE. Methods The medical records of patients who underwent pleurodesis in Aichi Medical University between March 2008 and February 2013, the period before the approval of talc in Japan, were retrospectively analyzed. Results A total of 84 patients underwent pleurodesis, all using OK-432. ILD occurred in 13 patients (15.5%). The development of ILD after pleurodesis was significantly associated with old age (odds ratio [OR]: 4.82, 95% confidence interval [CI]: 1.22-19.08) and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment (OR: 5.97, CI: 1.7-20.9). A multivariate analysis revealed that >67 years of age (p=0.01) and EGFR-TKI treatment (p=0.02) were significantly associated with the development of pleurodesis-related ILD. Among the patients who received both pleurodesis and EGFR-TKIs (n=23), 8 patients developed ILD. All of these patients were receiving EGFR-TKI therapy at the time of pleurodesis or within 30 days after pleurodesis. In contrast, no cases of ILD were observed among the patients who stopped EGFR-TKIs before pleurodesis or started EGFR-TKIs at more than 30 days after pleurodesis. Conclusion ILD seemed to be a frequent complication of pleurodesis in patients using OK-432, especially elderly patients and those who underwent pleurodesis while receiving EGFR-TKI therapy or who started EGFR-TKI therapy within 30 days after pleurodesis.


Internal Medicine | 2015

Metastatic embryonal carcinoma mimicking locally advanced non-small cell lung cancer.

Hiroki Numanami; Daisuke Takahashi; Emiko Takahashi; Eisuke Katsuda; Seiji Kamei; Katsuya Naruse; Kenji Baba; Masayuki Haniuda; Toyoharu Yokoi; Etsuro Yamaguchi; Akihito Kubo

A 50-year-old man with a history of smoking of 45 pack-years underwent right lower lobectomy after neoadjuvant chemoradiotherapy for locally advanced non-small cell lung cancer diagnosed on a bronchial biopsy and standard imaging examinations, including chest-abdominal contrast-enhanced computed tomography (CT) and whole-body F-18 fluorodeoxyglucose positron emission tomography/CT. Left orchiectomy was performed simultaneously to treat the slightly swollen left testis, which had remained unchanged for over five years. The thoracic tumor was proven to be in pathological complete remission and the testicular lesion was pathologically diagnosed as an embryonal carcinoma. Furthermore, a pathological reevaluation of the preoperative bronchial biopsy specimen revealed the lung tumor to be a metastatic embryonal carcinoma.


Breast Cancer | 2016

Targeted sonography using an image fusion technique for evaluation of incidentally detected breast lesions on chest CT: a pilot study

Junko Kousaka; Shogo Nakano; Takahito Ando; Rie Tetsuka; Kimihito Fujii; Miwa Yoshida; Yukako Shiomi-Mouri; Manami Goto; Yuko Imai; Tsuneo Imai; Takashi Fukutomi; Eisuke Katsuda; Tsuneo Ishiguchi; Osamu Arai


CardioVascular and Interventional Radiology | 2014

Ethanolamine oleate sclerotherapy combined with transarterial embolization using n-butyl cyanoacrylate for extracranial arteriovenous malformations.

Akira Kitagawa; Yuichiro Izumi; Makiyo Hagihara; Seiji Kamei; Shuji Ikeda; Eisuke Katsuda; Junko Kimura; Toyohiro Ota; Tsuneo Ishiguchi


Japanese Journal of Radiology | 2015

Uterine artery embolization by use of porous gelatin particles for symptomatic uterine leiomyomas: comparison with hand-cut gelatin sponge particles.

Yuichiro Izumi; Shuji Ikeda; Akira Kitagawa; Eisuke Katsuda; Makiyo Hagihara; Seiji Kamei; Toyohiro Ota; Tsuneo Ishiguchi


Japanese Journal of Radiology | 2012

Oblique approach for CT-guided liver radiofrequency ablation using multiplanar reformation images in hepatocellular carcinoma

Seiji Kamei; Joe Matsuda; Makiyo Hagihara; Akira Kitagawa; Yuichiro Izumi; Eisuke Katsuda; Yukihiko Oshima; Shuji Ikeda; Junko Kimura; Toyohiro Ota; Toshiki Kawamura; Tsuneo Ishiguchi


Biomarkers in Medicine | 2018

Clinical significance of serum anti-GM-CSF autoantibody levels in autoimmune pulmonary alveolar proteinosis

Masaki Nishimura; Etsuro Yamaguchi; Ayumu Takahashi; Nobuhiro Asai; Eisuke Katsuda; Toyohiro Ohta; Yoshinori Ohtsuka; Kenshi Kosaka; Ayako Matsubara; Hiroyuki Tanaka; Norihito Yokoe; Akihito Kubo; Satoshi Konno; Kenji Baba

Collaboration


Dive into the Eisuke Katsuda's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Seiji Kamei

Aichi Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Akihito Kubo

Aichi Medical University

View shared research outputs
Top Co-Authors

Avatar

Akira Kitagawa

Aichi Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yuichiro Izumi

Aichi Medical University

View shared research outputs
Top Co-Authors

Avatar

Junko Kimura

Aichi Medical University

View shared research outputs
Top Co-Authors

Avatar

Shuji Ikeda

Aichi Medical University

View shared research outputs
Top Co-Authors

Avatar

Toyohiro Ota

Aichi Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge